Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03124537 · ClinicalTrials.gov registry record · NA

Increasing Physical Activity Among Sedentary Older Adults:What, Where, When, and With Whom

A NA study of Aging and Self Efficacy, sponsored by Brandeis University.

Completed
Registry status
NA
Development phase
86
Enrollment target
1
Study location

NCT03124537: Completed NA study of Aging and Self Efficacy, sponsored by Brandeis University.

NCT03124537 is a NA study of Aging and Self Efficacy that has completed, run by Brandeis University. The registered enrollment target is 86 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03124537, a NA study of Aging and Self Efficacy, has completed, sponsored by Brandeis University.

COMPLETED
Registry status
NA
Development phase
86 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to develop a smart phone app to administer a behavior change program that helps adults to increase daily steps by planning where, when, and with whom to walk. The investigators tested the effectiveness of the walking program app for increasing the number of daily steps among sedentary older adults. The investigators examined the effects on self-efficacy and social integration/support.

Primary Outcome

Number of steps recorded daily on the phone app, weekly step averages

Interventions

  • BEHAVIORAL App Experimental condition
  • BEHAVIORAL App Condition Control

Study Locations (1)

Massachusetts

  • Brandeis University - Waltham

Trial Details

FieldValue
Enrollment Target 86 participants
Start Date 2017-10-16
Est. Completion 2019-07-09
Phase NA
Brandeis University

8 total trials

What the finished NCT03124537 record still lists

NCT03124537 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 86 participants, a relatively small participant target, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (96% lower).

The record links to 4 conditions, with Aging appearing as the primary indexed condition, and to 2 interventions - of which App Experimental condition is the first listed.

NCT03124537 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03124537 about?

NCT03124537 is a clinical study titled "Increasing Physical Activity Among Sedentary Older Adults:What, Where, When, and With Whom". The goal of this study is to develop a smart phone app to administer a behavior change program that helps adults to increase daily steps by planning where, when, and with whom to walk. The investigators tested the effectiveness of the walking program app for increasing the number of daily steps amon...

What is the current status of trial NCT03124537?

This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2017-10-16. Estimated completion is 2019-07-09.

What conditions does trial NCT03124537 study?

This clinical trial studies the following conditions: Aging, Self Efficacy, Sedentary Lifestyle, Control Locus.

What interventions are being tested in trial NCT03124537?

The interventions under investigation include: App Experimental condition (BEHAVIORAL), App Condition Control (BEHAVIORAL).

Who is sponsoring clinical trial NCT03124537?

This trial is sponsored by Brandeis University, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03124537 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03124537's enrollment target sits among peer trials

86 106th of 262 higher than 157 of 262 other Aging trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01639508 · 86 participants · Phase 2

    Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity

  • NCT03519269 · 86 participants · NA

    Navio Robotic Versus Conventional Total Knee Arthroplasty

  • NCT04132999 · 86 participants · NA

    PAP for Children With DS and OSAS

  • NCT04545957 · 86 participants · NA

    Jump: MR Simulation For Radiation Therapy Master Protocol

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03124537, the US trial registry maintained by the National Library of Medicine. NCT03124537 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.